Interleukin-4 and Epidermal Growth Factor Receptor in Colorectal Cancer
Author Information
Author(s): L. Kaklamanis, K.C. Gatter, N. Mortensen, A.L. Harris
Primary Institution: John Radcliffe Hospital
Hypothesis
The study investigates the role of IL-4R and EGFR in the progression of colorectal cancer.
Conclusion
IL-4 receptors are expressed in over 80% of colorectal adenocarcinomas, with many cases also showing coexpression of EGFR.
Supporting Evidence
- IL-4 receptors were found in 40 out of 44 colorectal adenocarcinomas.
- All polyps and non-neoplastic colonic mucosa were positively stained for IL-4R.
- Coexpression of IL-4R and EGFR was observed in 60% of IL-4R positive cases.
- Expression of EGFR was found in 22 out of 45 carcinomas.
- 25 out of 45 patients showed lymph node involvement by tumor cells.
Takeaway
This study looked at how two proteins, IL-4R and EGFR, are found in colon cancer. Most cancer samples had IL-4R, which might help doctors understand how the cancer grows.
Methodology
The study used immunohistochemical staining to assess IL-4R and EGFR expression in tumor samples from patients with colorectal cancer.
Limitations
The study is limited by the small sample size and the focus on specific tumor types.
Participant Demographics
The study included 44 patients with primary colon cancer and one with anal squamous cell carcinoma.
Statistical Information
P-Value
0.001 < P < 0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website